Safilo Group S.p.A. (SAFLY)
OTCMKTS · Delayed Price · Currency is USD
2.290
+0.060 (2.69%)
At close: Jul 1, 2025
Revance Therapeutics Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Net Income | 46.4 | 22.3 | -24.65 | 54.16 | 21.28 | -72.97 | Upgrade |
Depreciation & Amortization | 35.11 | 36.19 | 49.73 | 42.3 | 46.02 | 49.09 | Upgrade |
Other Amortization | 4.27 | 4.27 | 5.5 | 6.09 | 7.2 | 10.29 | Upgrade |
Other Operating Activities | -14.07 | -0.13 | -4.37 | -31.04 | -36.36 | -31.98 | Upgrade |
Change in Accounts Receivable | 4.7 | -5.86 | 6.34 | -36.22 | 6.89 | 6.35 | Upgrade |
Change in Inventory | 13.82 | 25.72 | 22.65 | -17.62 | -25.82 | 36.67 | Upgrade |
Change in Accounts Payable | -0.18 | -9.55 | -5.75 | -14.84 | 6.27 | -0.49 | Upgrade |
Change in Other Net Operating Assets | 9.23 | 3.27 | -1.73 | 6.33 | -8.17 | -0.06 | Upgrade |
Operating Cash Flow | 89.55 | 76.22 | 47.71 | 9.16 | 17.3 | -3.1 | Upgrade |
Operating Cash Flow Growth | 65.99% | 59.74% | 421.10% | -47.06% | - | - | Upgrade |
Capital Expenditures | -9.21 | -11.57 | -10.53 | -12.73 | -13.22 | -13.44 | Upgrade |
Sale of Property, Plant & Equipment | 0.04 | 0.09 | 10.51 | 0.2 | 10.19 | 2.84 | Upgrade |
Cash Acquisitions | 11.87 | - | -5.95 | - | - | -111.78 | Upgrade |
Sale (Purchase) of Intangibles | -1.77 | -37.14 | -2.69 | -3.13 | -6.74 | -6.84 | Upgrade |
Investment in Securities | -0.25 | -0.25 | - | - | - | - | Upgrade |
Other Investing Activities | - | - | - | -0 | 0 | - | Upgrade |
Investing Cash Flow | 0.68 | -48.87 | -8.65 | -15.67 | -9.76 | -129.22 | Upgrade |
Long-Term Debt Issued | - | - | - | 147 | - | 198.47 | Upgrade |
Long-Term Debt Repaid | - | -42.64 | -39.96 | -163.03 | -129.87 | -29.58 | Upgrade |
Net Debt Issued (Repaid) | -42.99 | -42.64 | -39.96 | -16.03 | -129.87 | 168.89 | Upgrade |
Issuance of Common Stock | 0.06 | 0.36 | 0.04 | 0.09 | 133.06 | - | Upgrade |
Repurchase of Common Stock | -12.18 | -11.79 | - | - | - | - | Upgrade |
Other Financing Activities | -0.76 | -0.76 | -0.55 | -0.88 | -1.12 | - | Upgrade |
Financing Cash Flow | -55.87 | -54.83 | -40.47 | -16.81 | 2.07 | 168.89 | Upgrade |
Foreign Exchange Rate Adjustments | -3.41 | 0 | -1.41 | 2.03 | 3.43 | -4.52 | Upgrade |
Net Cash Flow | 30.96 | -27.48 | -2.81 | -21.29 | 13.04 | 32.05 | Upgrade |
Free Cash Flow | 80.34 | 64.65 | 37.19 | -3.58 | 4.08 | -16.54 | Upgrade |
Free Cash Flow Growth | 84.10% | 73.85% | - | - | - | - | Upgrade |
Free Cash Flow Margin | 8.04% | 6.51% | 3.63% | -0.33% | 0.42% | -2.12% | Upgrade |
Free Cash Flow Per Share | 0.19 | 0.15 | 0.09 | -0.01 | 0.01 | -0.06 | Upgrade |
Cash Interest Paid | 7.75 | 7.75 | 9.8 | 6.13 | 6.86 | 6.69 | Upgrade |
Cash Income Tax Paid | 5.85 | 5.85 | 8.72 | 2.41 | 1.14 | 0.05 | Upgrade |
Levered Free Cash Flow | 113.8 | 14.48 | 83.82 | -3.89 | 4.89 | 54.57 | Upgrade |
Unlevered Free Cash Flow | 117.66 | 20.85 | 91.19 | 1.34 | 13.59 | 62.1 | Upgrade |
Change in Net Working Capital | -44.62 | 2.6 | -21.51 | 62.27 | 40.95 | -61.16 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.